Y-mAbs Therapeutics, Inc. - Common Stock (YMAB)
4.8000
+0.3000 (6.67%)
NASDAQ · Last Trade: Apr 2nd, 7:56 PM EDT
Via Benzinga · March 21, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · March 13, 2025
Via Benzinga · March 13, 2025

Via Benzinga · March 5, 2025

Via Benzinga · November 18, 2024

Via Benzinga · November 7, 2024

Via Benzinga · January 7, 2025

Via Benzinga · August 13, 2024

Via Benzinga · March 6, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via Benzinga · February 29, 2024

Via Benzinga · November 22, 2024

Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio.
Via Benzinga · October 30, 2024

The company didn't quite meet expectations for either trailing results or full-year guidance.
Via The Motley Fool · August 12, 2024

YMAB stock results show that Y-mAbs Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Via Benzinga · August 12, 2024

Via Benzinga · July 2, 2024

YMAB stock results show that Y-mAbs Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 7, 2024

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.
Via Benzinga · March 1, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday.
Via Benzinga · March 1, 2024

Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected third-quarter financial results and issued guidance.
Via Benzinga · March 1, 2024

Via Benzinga · March 1, 2024

Via Benzinga · February 29, 2024